Does adjuvant therapy with letrozole improve survival in postmenopausal women with early-stage breast cancer?
- PMID: 16826213
- DOI: 10.1038/ncponc0537
Does adjuvant therapy with letrozole improve survival in postmenopausal women with early-stage breast cancer?
Comment on
-
A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.N Engl J Med. 2005 Dec 29;353(26):2747-57. doi: 10.1056/NEJMoa052258. N Engl J Med. 2005. PMID: 16382061 Clinical Trial.
Similar articles
-
Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in postmenopausal women with hormone-receptor positive early breast cancer from a Canadian perspective.Breast Cancer Res Treat. 2008 Apr;108(3):375-87. doi: 10.1007/s10549-007-9607-7. Epub 2007 Jul 26. Breast Cancer Res Treat. 2008. PMID: 17653859 Clinical Trial.
-
Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.Am J Manag Care. 2006 Jul;12(7):374-86. Am J Manag Care. 2006. PMID: 16834524
-
Extending the benefits of adjuvant therapy in early HR+ breast cancer.Breast Cancer Res Treat. 2008 Dec;112 Suppl 1:45-52. doi: 10.1007/s10549-008-0129-8. Epub 2008 Sep 11. Breast Cancer Res Treat. 2008. PMID: 18785006
-
Beyond tamoxifen: extended and late extended endocrine therapy in postmenopausal early breast cancer.Cancer Treat Rev. 2008 Apr;34(2):137-44. doi: 10.1016/j.ctrv.2007.09.004. Epub 2007 Nov 14. Cancer Treat Rev. 2008. PMID: 18006236 Review.
-
The Breast International Group 1-98 trial: big results for women with hormone-sensitive early breast cancer.Expert Rev Anticancer Ther. 2007 May;7(5):627-34. doi: 10.1586/14737140.7.5.627. Expert Rev Anticancer Ther. 2007. PMID: 17492927 Review.
Publication types
LinkOut - more resources
Full Text Sources